Cite

HARVARD Citation

    Chihara, M. et al. (2018). Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis. Journal of immunology research. p. . [Online]. 
  
Back to record